Insights

Expanding Oncology Portfolio Partner Therapeutics is actively involved in developing and commercializing innovative cancer therapies, such as zenocutuzumab and Leukine, presenting promising opportunities for partnership or distribution agreements with oncology-focused healthcare providers and research institutions.

Strategic Collaborations The company has recently strengthened partnerships with leading entities like Diaceutics and Merus, indicating a propensity for collaborative growth and licensing deals, which could open avenues for expanding distribution channels or joint marketing initiatives.

Focus on Precision Medicine Partner Therapeutics is investing in targeted therapies for specific cancer subtypes like NRG1+ non-small cell lung and pancreatic cancer, suggesting potential opportunities to engage with specialized oncology clinics and personalized treatment centers.

Investment and Growth With significant funding and a revenue base of up to $100 million, the company is positioned for scaling operations and broadening its product pipeline, making it a compelling partner for providers and investors seeking innovative cancer solutions.

Innovative Market Position Their focus on outcome-driven therapies and proactive engagement with medical communities creates a strategic advantage, offering sales teams opportunities to collaborate with healthcare professionals committed to improving patient quality of life through advanced cancer treatments.

Partner Therapeutics Tech Stack

Partner Therapeutics uses 8 technology products and services including Veeva Vault, jQuery Migrate, Zepto, and more. Explore Partner Therapeutics's tech stack below.

  • Veeva Vault
    Enterprise Content Management
  • jQuery Migrate
    Javascript Libraries
  • Zepto
    Javascript Libraries
  • PHP
    Programming Languages
  • Paylocity
    Recruitment Marketing
  • CVS
    Source Code Management
  • Adobe Creative Suite
    Visualisation Software
  • prettyPhoto
    Web Tools And Plugins

Media & News

Partner Therapeutics's Email Address Formats

Partner Therapeutics uses at least 1 format(s):
Partner Therapeutics Email FormatsExamplePercentage
First.Last@partnertx.comJohn.Doe@partnertx.com
67%
FLast@partnertx.comJDoe@partnertx.com
26%
F.Last@partnertx.comJ.Doe@partnertx.com
7%

Frequently Asked Questions

What is Partner Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Partner Therapeutics's official website is partnertx.com and has social profiles on LinkedInCrunchbase.

What is Partner Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Partner Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Partner Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, Partner Therapeutics has approximately 184 employees across 2 continents, including North AmericaEurope. Key team members include Ceo: R. M.Chief Development Officer: P. G.Vice President Of Quality: L. R.. Explore Partner Therapeutics's employee directory with LeadIQ.

What industry does Partner Therapeutics belong to?

Minus sign iconPlus sign icon
Partner Therapeutics operates in the Biotechnology Research industry.

What technology does Partner Therapeutics use?

Minus sign iconPlus sign icon
Partner Therapeutics's tech stack includes Veeva VaultjQuery MigrateZeptoPHPPaylocityCVSAdobe Creative SuiteprettyPhoto.

What is Partner Therapeutics's email format?

Minus sign iconPlus sign icon
Partner Therapeutics's email format typically follows the pattern of First.Last@partnertx.com. Find more Partner Therapeutics email formats with LeadIQ.

How much funding has Partner Therapeutics raised to date?

Minus sign iconPlus sign icon
As of December 2025, Partner Therapeutics has raised $60M in funding. The last funding round occurred on Feb 01, 2018 for $60M.

When was Partner Therapeutics founded?

Minus sign iconPlus sign icon
Partner Therapeutics was founded in 2017.

Partner Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

WE'RE ALL IN FOR FIGHT AGAINST CANCER
Partner Therapeutics is devoted to developing and commercializing cancer medicines and combination therapies that can make a meaningful difference in the lives of cancer patients.  We are united in our passion for improving the treatment of cancer and our desire to make a meaningful contribution to outcomes.

THE PATIENT IS NUMBER ONE
We believe that being a cancer company begins and ends with the patient.  We strive to support patient needs throughout their treatment journey to help them make the treatment choices that are right for them and their loved ones.

FIGHTING CANCER IS TEAM SPORT
We believe that cancer is a complex, dynamic disease that requires a multi-faceted, multi-disciplinary approach to tackle.  We believe in teamwork at each stage of a therapy’s development, and seek to build teams of experts, both internally and externally, that cover the breadth and depth of the complex problem that is cancer.

We work with leading companies and investigators to ensure that our products are tested in the best settings, and in combination with highest potential regimens to maximize benefit to patients and to advance the understanding of cancer treatment.

We seek to engage all members of the cancer treatment team as well as thought-leading physicians and patient advocacy organizations to ensure that clear, complete and balanced information about our products is proactively communicated and readily available. We work to support the extraordinary dedication of the medical teams that represent the front lines in the war on cancer.  

OUTCOMES ARE OUR YARDSTICK
We believe that innovation is not enough.  In the challenging world of today’s healthcare climate, we strive to develop and assess our products based on the real-world impact they have in improving the quality and duration of our patients’ lives.  We measure our success in the birthdays, anniversaries and other important life moments that our patients are able to enjoy.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $60M

    Partner Therapeutics has raised a total of $60M of funding over 1 rounds. Their latest funding round was raised on Feb 01, 2018 in the amount of $60M.

  • $50M$100M

    Partner Therapeutics's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $60M

    Partner Therapeutics has raised a total of $60M of funding over 1 rounds. Their latest funding round was raised on Feb 01, 2018 in the amount of $60M.

  • $50M$100M

    Partner Therapeutics's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.